Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3991563rdf:typepubmed:Citationlld:pubmed
pubmed-article:3991563lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:3991563lifeskim:mentionsumls-concept:C1511362lld:lifeskim
pubmed-article:3991563lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:3991563lifeskim:mentionsumls-concept:C0020835lld:lifeskim
pubmed-article:3991563lifeskim:mentionsumls-concept:C0333562lld:lifeskim
pubmed-article:3991563pubmed:dateCreated1985-6-19lld:pubmed
pubmed-article:3991563pubmed:abstractTextIn order to develop an experimental IgA nephropathy, C3H/HeJ mice, high producers of IgA, were strongly immunised orally by ferritin and compared to C3H/eB mice. After immunisation, serum IgA and IgG titres increased significantly only in C3H/HeJ mice. Specific antiferritin antibody could be detected in the serum. Mesangial IgA deposits were present in most of C3H/HeJ mice after immunisation and were significantly higher than in C3H/eB mice. No ferritin deposits could be detected in the kidney. No clinical manifestation appeared in these animals.lld:pubmed
pubmed-article:3991563pubmed:languageenglld:pubmed
pubmed-article:3991563pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3991563pubmed:citationSubsetIMlld:pubmed
pubmed-article:3991563pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3991563pubmed:statusMEDLINElld:pubmed
pubmed-article:3991563pubmed:issn0308-9401lld:pubmed
pubmed-article:3991563pubmed:authorpubmed-author:BerthouxF CFClld:pubmed
pubmed-article:3991563pubmed:authorpubmed-author:GeninCClld:pubmed
pubmed-article:3991563pubmed:authorpubmed-author:SabatierJ CJClld:pubmed
pubmed-article:3991563pubmed:issnTypePrintlld:pubmed
pubmed-article:3991563pubmed:volume21lld:pubmed
pubmed-article:3991563pubmed:ownerNLMlld:pubmed
pubmed-article:3991563pubmed:authorsCompleteYlld:pubmed
pubmed-article:3991563pubmed:pagination703-8lld:pubmed
pubmed-article:3991563pubmed:dateRevised2008-2-26lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:meshHeadingpubmed-meshheading:3991563-...lld:pubmed
pubmed-article:3991563pubmed:year1985lld:pubmed
pubmed-article:3991563pubmed:articleTitleIgA mesangial deposits in C3H/HeJ mice after oral immunisation.lld:pubmed
pubmed-article:3991563pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3991563pubmed:publicationTypeComparative Studylld:pubmed